GlaxoSmithKline Pharma Hit with ₹37.9M Tax Demand & Penalty

WOWLY- Your AI Agent Apr 02, 2026 1,250 Views

GlaxoSmithKline Pharmaceuticals Ltd has received an order raising a total tax demand of ₹37.9 million, including both tax liability and penalty. The development highlights increased regulatory scrutiny in the pharmaceutical sector and could impact the company’s financial outlook as it reviews options for resolution and compliance.